Concanavalin A (Con A) is a tetrameric plant lectin that disrupts plasma membrane-cytoskeletal interactions and alters plasma membrane fluidity. We used Con A as a probe to explore ,-adrenergic and muscarinic cholinergic receptor-mediated regulation of cAMP in intact neonatal rat ventricular myocytes. Preincubation with Con A, 0.5 ,ug/ml, attenuated 1 MM (-)-norepinephrine (NE)-induced downregulation of ,-adrenergic receptors and resulted in a 50% augmentation of cAMP accumulation stimulated by 1 MuM NE. Con A also augmented forskolin (1-10 MM)-stimulated cAMP accumulation by an average of 37% (P < 0.05); however, Con A preincubation had no effect on basal or cholera toxin-stimulated cAMP content. The muscarinic cholinergic agonist carbachol (1-100 ,M) decreased 1 MM NE-stimulated cAMP generation by an average of 32% (n = 7, P < 0.05); preincubation with Con A further enhanced the inhibitory effect of carbachol by 18% (n = 7, P < 0.05). Carbachol (1 ,uM) for 2 h decreased muscarinic cholinergic receptor density in whole cells by 33%; preincubation with Con A prevented this receptor downregulation. Con A pretreatment did not affect (-)-isoproterenol-or forskolin-stimulated adenylate cyclase activity in cell homogenates, suggesting that an intact cytoarchitecture is necessary for Con A to augment cAMP formation.
Introduction
The adenylate cyclase system, which mediates cellular responses to a variety ofhormones and neurotransmitters, is composed of three distinct components that interface with the in-ner surface of the plasma membrane: the hormone receptor, the guanine nucleotide-binding proteins (G-proteins) and the catalytic unit (1) . Recent evidence suggests that these components also interact with the cytoskeleton, a highly complex array of microtubules and microfilaments that provide the cell with shape, motility, and internal spatial organization (2) (3) (4) (5) (6) . Although it is well established that these cytoskeletal elements can regulate the functional properties ofthe plasma membrane (7, 8) , the potential mechanism(s) were, until recently, poorly defined. Current evidence suggests that both membrane-associated components of adenylate cyclase-linked pathways and cytoskeletal elements are substrates for protein kinase-mediated phosphorylation, which may modulate coupling to their effector systems (9) (10) (11) (12) (13) . Thus, plasma membrane-cytoskeletal interactions may be important participants in the regulation of transmembrane signaling and thereby directly affect cellular responses to external stimuli (14, 15) .
In myocardial cells there is little information regarding the possible regulatory role of the plasma membrane-cytoskeletal complex and adenylate cyclase-linked signal transduction. Concanavalin A (Con A),' a tetrameric lectin derived from the jack bean, Cancanvalia ensiformis, binds to specific membrane receptors (16, 17) , increases plasma membrane fluidity (18) , and may perturb plasma membrane-cytoskeletal relations (16) . In this study we explored the effects of Con A on components of the fl-adrenergic-and muscarinic cholinergic-adenylate cyclase system in intact neonatal rat ventricular myocytes. Our results suggest the possibility that both alterations in membrane fluidity and in plasma membrane-cytoskeletal interactions are important regulators of transmembrane signaling because both stimulatory and inhibitory pathways coupled to adenylate cyclase appear to be dependent on such interactions. Furthermore, the maintenance of an intact cellular architecture appears to be an important prerequisite to cytoskeletal modulation of transmembrane signaling.
Methods
Ventricular myocardial cell preparation. Primary cell cultures were composed of single isolated ventricular myocytes prepared from hearts of l-d-old rats as previously described (19) . Cells obtained by brief alternating cycles of room temperature trypsinization and mechanical dissociation were washed and preplated with 5% bovine calf serum to reduce the number of contaminating nonmyocardial cells. After 30 min nonattached myocardial cells were removed, counted, and diluted in culture medium containing 5% bovine calf serum and plated at a density of -380 cells per mm2 into 100-mm plastic dishes (Falcon; Becton Dickinson and Co., Mountain View, CA) or 8.6 X I04 cells/well into 24-well culture plates (Falcon) for cAMP assay. The standard serum-free medium was MEM with Hanks' salt solution supplemented with 1.5 MM vitamin B12 and 50 U/ml penicillin. Through day 3 the medium contained 0.1 mM bromodeoxyuridine to prevent low level nonmyocardial cell proliferation as previously described (19) . Medium was routinely changed on day 4.
Cell yield was 5-7 million per heart of which 90% were viable.
All cultures were kept at 370C in humidified air with 1% CO2 to maintain pH 7.3. The cultures contained > 90% myocardial cells and cell numbers were constant over time.
Con A was dissolved in sterile double-distilled water to a stock concentration of 5 mg/ml. (-)-Norepinephrine was dissolved in 1 mM HCI; forskolin was dissolved in DMSO to a final concentration of0.1%, which did not alter cAMP levels. All other drugs, carbachol, cholera toxin, and guanosine 5'-triphosphate (GTP) were dissolved in doubledistilled water. All experiments were performed in intact cells preincubated for 30 min in Hanks' medium supplemented with 5% bovine calf serum containing 1 mM 3-isobutyl-l-methylxanthine (IBMX), a phosphodiesterase inhibitor.
Radioligand binding studies. Radioligand binding studies were carried out on days 5-7 after plating. Cells were incubated with reagents (Con A, (-)-norepinephrine, carbachol) for designated time periods (see Results). Myocardial cells were prepared for radioligand binding studies by rapid washing with 5 ml of the following "CGP buffer": 153 mM NaCl, 10 mM Tris-HCI, 5 mM MgCl2, pH 7.4, or "muscarinic buffer": 110 mM NaCI, 5.3 mM KC1, 1.8 mM CaCI2, 1.0 mM MgCl2, 25 mM glucose, 20 mM Hepes (N-2-hydroxyethylpiperazine-IV-2-ethanesulfonic acid), pH adjusted to 7.4 with HCl. Both harvesting buffers contained 0.65 mU aprotinin, a protease inhibitor. Cells were immediately harvested using a plastic spatula and suspended in the appropriate ice-cold buffer. Cell aggregation in this suspension was minimized by three gentle strokes in a glass homogenizing tube and filtration through a single layer of 110 mesh nylon gauze (Nitex, Switzerland). Preliminary experiments documented > 80% trypan blue exclusion using this method.
The cell suspension was then incubated with (+)-[3HJ4-(3-t-butylamino-2-hydroxypropoxy)benzimidazol-2-one hydrochloride (3H-CGP-12177) (0.5-15.0 nM) or 3H-methyl-scopolamine (0.2-20 nM) in a total volume of0.5 ml at 37°C for 30 min in 12 X 75-mm polypropylene tubes. Nonspecific binding was determined using 1 MM (-)-propranolol or 1 MM atropine, respectively. The binding reaction was terminated by adding 5 ml ice-cold CGP buffer or ice-cold 50 mM Tris HCI, pH 7.5, followed by immediate filtration through glass fiber filters (Whatman GF/C; Whatman Inc., Clifton, NJ) using a Brandel Cell Harvester (Brandel Laboratories, Gaithersburg, MD). Retained radioactivity was determined 24 h after addition of 7 ml ofscintillation fluid (Cytoscint; WestChem, San Diego, CA) in a scintillation counter (Model LS 350; Beckman Instruments, Inc., Fullerton, CA) with an efficiency of 36%. Specific binding was defined as the difference between total binding and nonspecific binding and ranged from 65-80% for both 3H-CGP-12177 and 3H-methyl-scopolamine. All determinations were performed in duplicate.
Equilibrium binding studies using '251-iodocyanopindolol (ICYP) were performed in triplicate in a particulate preparation as described below (20) . Nonspecific binding was determined using 1 MM (-)-propranolol; specific binding ranged from 75 to 93%. For both radioligands, the maximum number of binding sites (B,.,.) and the equilibrium Kd were determined by least squares linear regression analysis using the method of Scatchard (21) . Six to eight points were measured for each determination of B.. Protein was measured by the method of Lowry et al. (22) , using bovine serum albumin as standard.
For construction of (-)-isoproterenol competition curves and adenylate cyclase determinations, cardiac myocyte membranes were prepared by washing cells three times with 1 mM Tris-HCI/2 mM EGTA buffer, pH 7.4, with subsequent in situ lysis for 30 min at 4°C, as previously described (20) . This particulate preparation was harvested using a plastic spatula and placed in 18 X 100-mm polycarbonate tubes and centrifuged at 40,000 g for 30 min at 4°C. The During the course of this study a further modification of this assay procedure as described by Alvarez and Daniels (24a) was used (method No. 2). This modification was used for experiments examining (-)-isoproterenol-mediated activation of adenylate cyclase. Samples were incubated in boiling water for 4 min rather than centrifuged and columns containing 2.6 g neutral alumina were eluted with 5 ml 0.1 M ammonium acetate instead of Tris-HCl. Using this approach background counts were virtually zero. cAMP radioimmunoassay. Intracellular cAMP accumulation was determined using a modification of the procedure described by Steiner et al. (25) . Briefly, 5-7-d-old myocardial cells plated in 24-well culture dishes (Falcon) were preincubated with (-)-norepinephrine, forskolin, or carbachol in the presence or absence of Con A. Immediately after incubation with agonist in the presence of 1 mM IBMX, medium was aspirated and cells were eluted with 3 ml of 95% ethanol. The eluent was transferred to 12 x 75-mm borosilicate glass tubes, air dried, and stored at 4°C for up to 1 mo, which did not affect the results. At the time of assay the pellet was brought to room temperature and resuspended in 0.3 ml 0.05 M NaOAC, pH 6.2; 0.1 ml of this resuspension or 0.1 ml ofcAMP standard was added to 0.1 ml of 123I-succinyl-cAMP tyrosine methyl ester tracer (6-12,000 cpm). 100 Ml of goat cAMP antibody in sodium acetate buffer containing 2 mg/ml bovine gamma globulin was then added in a final dilution of 1:240,000 and incubated overnight on ice; 1.5 ml polyethylene glycol(PEG)-gamma globulin solution (160 mg PEG per ml 1% bovine gamma globulin solution) was added to each tube and the precipitated antibody-antigen complex centrifuged at 40,000 rpm (Sorvall TB3500) for 
Results
ConcanavalinA inhibitsagonist-induced j-adrenergicandmuscarinic cholinergic receptor downregulation. We initially determined the effect of Con A on homologous regulation of the f3-adrenergic receptor. Incubation ofintact neonatal rat ventricular myocytes with 1 MM (-)-norepinephrine (NE) for 2 h resulted in a 41% decrease in cell surface fl-adrenergic receptor density using the hydrophilic radioligand 3H-CGP-12177 (Fig.  1) . Kd values in the control cells averaged 0.67±0.15 nM and were not significantly different from the NE-treated cells. Preincubation with Con A 0.5 ug/ml for 30 min before NE exposure attenuated this agonist-induced f3-adrenergic receptor downregulation. Con A alone had no effect on cell surface receptor density; however, it did substantially increase antagonist affinity by 61%, from 0.67±0.15 to 1.7±0.19 nM (P < 0.025). By contrast, agonist affinity for the f3-adrenergic receptor as measured by (-)-isoproterenol competition was unaffected by Con A; furthermore, Con A had no effect on the GTP-mediated decrease in receptor affinity for agonist (Fig. 2) . Concanavalin A influences postreceptor regulation of cAMP. To determine whether Con A could likewise augment cAMP formation via a postreceptor mechanism, we incubated Con A-treated myocytes with the diterpene forskolin, which stimulates cAMP accumulation by interaction with the catalytic unit ofadenylate cyclase (27) and likely in part by interaction with the stimulatory guanine nucleotide regulatory protein (G() (28) . As shown in Fig. 5 , Con A pretreatment significantly increased 1 and 10 MM forskolin-stimulated cAMP formation compared with control. We then asked whether Con A interacts with the stimulatory GTP-binding protein G, in the absence ofan effect on the catalytic subunit. Cholera toxin directly stimulates G, by irreversible ADP-ribosylation of the a-subunit and inhibits GTPase activity. Cardiac myocytes were preincubated for 30 min with Con A before exposure to 10 ug/ml of cholera toxin for 5 or to 20.5±4.7 pmol/well after incubation with 1 and 10 M forskolin, respectively, this difference did not quite reach statistical significance (P = 0.07). By contrast, the forskolin-stimulated cAMP levels in the myocytes pretreated with Con A (closed circles) were significantly increased when 1 and 10 uM forskolin were compared (21.5±3.5 vs. 34.2±8.1 pmol/well; P < 0.05). *P < 0.05 vs. the untreated control value; each value represents mean±SEM from five separate experiments. stimulated cAMP synthesis, Con A did not alter cholera toxinstimulated cAMP accumulation at these time points (Table I) . Using the method of Jones et al. (29), we permeabilized cells with 10 gM/ml saponin. Subsequent incubation with 0.5 ,ug/ ml Con A had no effect on the ability of 100 mM GTPyS to augment cAMP accumulation (n = 3-4, data not shown). These observations, coupled with the data presented above, suggest that Con A augments cAMP generation both by receptor-mediated and postreceptor mechanisms; the latter appears to require involvement of the catalytic subunit of adenylate cyclase.
To investigate the potential importance ofan intact cytoarchitecture to the augmentation ofcAMP generation by Con A, membranes from myocytes preincubated in 0.5 /g/ml Con A for 30 min were prepared. Adenylate cyclase activity stimulated by 100 MM forskolin in the presence and absence of varying concentrations of the nonhydrolyzable GTP analogue guanyl-5'-imidodiphosphate (Gpp(NH)p) was determined (Table II). In contrast to the data obtained in intact myocytes using measurements of cAMP, Con A pretreatment did not enhance Intact ventricular myocytes were preincubated with 10 ug/ml cholera toxin for 5 and 30 min. Myocytes were preincubated with 1 mM IBMX/5% bovine calf serum for 30 min before cholera toxin exposure. All values are given as the mean±SEM, n = 3, P = NS. forskolin-stimulated adenylate cyclase activity in membranes.
These data suggest that preservation of intact membrane and intracellular spatial relations is required for Con A to augment the synthesis of cAMP.
We then investigated the possible interaction between Con A and the regulation ofcAMP via the pathway that utilizes the inhibitory guanine nucleotide protein, Gi. As expected, incubation with the muscarinic cholinergic receptor agonist carbachol (1-100 ,M) decreased cAMP stimulated by 1 MuM NE in intact myocytes (Fig. 6 ). To our surprise, however, 30 min of treatment with Con A before simultaneous addition of carba- In light ofthese data we wondered whether we could detect any change in the ability of pertussis toxin to ADP-ribosylate Gi after pretreatment with Con A. In two experiments, there was no effect on a 40-kD band observed on sodium dodecylsulfate polyacrylamide gel electrophoresis after incubation with 32P-NAD and 1 gg/ml pertussis toxin for 2 h, when membranes from Con A-pretreated cells were compared with control membranes (data not shown).
Discussion
This present study is the first to investigate the effects ofCon A on both stimulatory and inhibitory adenylate cyclase-linked pathways in cardiac myocytes. Our data demonstrate that Con A prevents both f3-adrenergic and muscarinic cholinergic-induced receptor downregulation while amplifying agonist-mediated signal transduction. The effect ofCon A on f3-adrenergic receptor downregulation was blocked by a selective inhibitor of this lectin, methyl a-D-methylmannopyranoside. Our observation that Con A prevents agonist-mediated jl-adrenergic receptor downregulation is consistent with those ofothers in various cells (30) (31) (32) . However, previous studies did not examine the effects of Con A on muscarinic cholinergic receptors or the influence of these agents on second messenger formation mediated by receptor and postreceptor pathways. A novel observation, not previously reported either in cardiac cells or to our knowledge in other systems, is that perturbation of the cell membrane by Con A results in either augmented inhibition or stimulation of cAMP synthesis, depending on the agonist employed. Thus Con A alters both stimulatory and inhibitory adenylate cyclase-linked pathways.
Both Waldo et al. (32) and Insel and Koachman (33) reported that adenylate cyclase activity did not increase in cell homogenates after incubation with Con A. Our inability to demonstrate enhanced receptor-(isoproterenol) and postreceptor-(forskolin) stimulated adenylate cyclase activity in homogenates prepared from cardiac myocytes preincubated with Con A (Table II) (28) . The absence of a Con A effect on cholera toxin-stimulated cAMP levels and on cAMP accumulation stimulated by GTPyS in permeabilized myocytes suggests that the postreceptor target of Con A is the catalytic subunit of adenylate cyclase. Together, these data suggest that Con A not only prevents agonist-mediated (l-adrengeric receptor downregulation but also alters interactions at levels beyond both the cell surface and agonist-receptor coupling.
Another possible mechanism of action of Con A is that it interferes with the normal interaction between protein kinase(s) and substrate(s). The role ofprotein kinases in the regulation of receptor-coupled transmembrane signaling is well established (for review see Sibley et al. (34] ). These kinases may have attachments that directly modulate cytoskeletal activity (15, 35) . In neonatal rat ventricular myocytes, the tumor-promoting phorbol ester 12-0-tetradecanoylphorbol-13-acetate (PMA) induces the transposition of protein kinase C (PKC) activity from a cytosolic to a membrane fraction (36) where it phosphorylates the fl-adrenergic receptor and induces its downregulation (37) . In rat C6 glioma cells Con A pretreatment prevents PMA-induced transposition of PKC activity from the cytosol to the plasma membrane (38) . Recent evidence indicates that in neonatal rat ventricular myocytes, PMA induces translocation of a PKC isozyme to cytoskeletal elements (39) . In recent experiments we found that 100 nM PMA induced fl-adrenergic receptor downregulation which was prevented by the protein kinase C inhibitor H-7 (40) . Additional experiments in neonatal rat ventricular myocytes indicate that Con A pretreatment prevents PMA-mediated fladrenergic receptor downregulation (unpublished observations). These data are consistent with an effect of Con A at multiple levels in the control of signal transduction, including receptor cycling and phosphorylation and G protein-catalytic unit interactions.
In summary, our data indicate that Con A influences signaling pathways mediated by the adenylate cyclase-muscarinic cholinergic receptor systems in neonatal rat ventricular myocytes. These observations are consistent with the hypothesis that interference with normal membrane-cytoskeletal interactions may perturb the spatial orientation of specific components ofthe receptor-effector coupling system, leading to alterations in transmembrane signaling. These observations represent further evidence of the complexity and diversity of mechanisms that modulate cellular responses to hormonal stimulation in cardiac myocytes.
